Phase 3 Study of SNF472 for Calciphylaxis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The primary objectives are to assess the efficacy, safety, and tolerability of SNF472 compared to placebo when added to background care for the treatment of calciphylaxis (CUA).
Epistemonikos ID: 75150bb0203aee990b3b6f006a7abf3176b14e6c
First added on: May 06, 2024